Skip to content

Clinical trials

Phase 1 Anemia, Sickle Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 1 Clear all

119 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20043
20053
20063
20071
20081
20092
20106
20113
20125
20136
20145
201510
20164
20175
20187
20196
20208
20216
20226
20235
20246
20257
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Terminated14
Recruiting13
Withdrawn8
Active, not recruiting6
Not yet recruiting5
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)11
Pfizer6
Emory University5
St. Jude Children's Research Hospital5
City of Hope Medical Center4
Global Blood Therapeutics4
Fulcrum Therapeutics3
National Institutes of Health Clinical Center (CC)3
University of Mississippi Medical Center3
AstraZeneca2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell119
beta-Thalassemia9
Thalassemia8
Hematologic Diseases6
Hemoglobinopathies6
Hemoglobin SC Disease5
Hypertension, Pulmonary5
Sickle Cell Trait5
Vaso-Occlusive Crises5
Acute Chest Syndrome4

Trials

Showing 26 to 50 of 119. Each trial links to its page on Pharma Observatory.

19 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.